🇺🇸 Simvastatin 40mg in United States

145 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myalgia — 25 reports (17.24%)
  2. Rhabdomyolysis — 23 reports (15.86%)
  3. Drug Interaction — 16 reports (11.03%)
  4. Blood Creatine Phosphokinase Increased — 13 reports (8.97%)
  5. Fatigue — 13 reports (8.97%)
  6. Muscle Spasms — 12 reports (8.28%)
  7. Pain In Extremity — 12 reports (8.28%)
  8. Acute Kidney Injury — 11 reports (7.59%)
  9. Arthralgia — 10 reports (6.9%)
  10. Muscular Weakness — 10 reports (6.9%)

Source database →

Simvastatin 40mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Simvastatin 40mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Simvastatin 40mg in United States?

Marc Goodman is the originator. The local marketing authorisation holder may differ — check the official source linked above.